U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06923215) titled 'Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver' on April 04.
Brief Summary: A 12-month prospective observational cohort study assessing eGDR's utility in diagnosing MAFLD (via FibroScan(R) CAP >=248 dB/m) and correlating it with steatosis/fibrosis severity. Secondary aims compare eGDR to FLI/FIB-4 scores and identify optimal diagnostic cut-offs
Study Start Date: July 30, 2025
Study Type: OBSERVATIONAL
Condition:
MAFLD
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Amira William Ayad Makar, Assiut University
Disclaimer: Curat...